EPO is used clinically for treatment of anemia and is considered generally safe. This patent teaches that administration of EPO can stimulate the differentiation of neurons. Currently this concept is being tested (at least in part) by Stem Cell Therapeutics who are conducting clinical trials using EPO together with hCG for the treatment of stroke.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.